Chest Pain — Ultrasonography in the Emergency Department
Citation(s)
Arntfield RT, Millington SJ Point of care cardiac ultrasound applications in the emergency department and intensive care unit--a review. Curr Cardiol Rev. 2012 May;8(2):98-108. Review.
Jensen MB, Sloth E [Transthoracic ultrasound: a necessary standard within intensive, acute and pre-hospital medicine]. Ugeskr Laeger. 2006 Dec 11;168(50):4393-6. Danish.
Lichtenstein DA, Mezière GA Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol. Chest. 2008 Jul;134(1):117-25. doi: 10.1378/chest.07-2800. Epub 2008 Apr 10. Erratum in: Chest. 2013 Aug;144(2):721.
Parlamento S, Copetti R, Di Bartolomeo S Evaluation of lung ultrasound for the diagnosis of pneumonia in the ED. Am J Emerg Med. 2009 May;27(4):379-84. doi: 10.1016/j.ajem.2008.03.009.
Zanobetti M, Poggioni C, Pini R Can chest ultrasonography replace standard chest radiography for evaluation of acute dyspnea in the ED? Chest. 2011 May;139(5):1140-7. doi: 10.1378/chest.10-0435. Epub 2010 Oct 14.
Ultrasonography in the Emergency Department. A Randomised Controlled Multicenter Study.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
